After $900 million and $500-plus million fund closures last week from Foresite Capital and JP Morgan, respectively, another firm wants to enter the upper echelons …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Transgender adults living in the rural Appalachian area of the U.S., were more likely to have cardiovascular disease risk factors, like tobacco use, obesity and
ALX Oncology is cutting two studies of its anti-CD47 drug evorpacept after it failed to show substantial efficacy. In its second-quarter report Thursday afternoon, ALX
A leaked version of a proposed agreement between India and the European Free Trade Association is causing alarm among civil society and patient advocacy groups